Cytokines and serotonin transporter in patients with major depression

被引:179
作者
Tsao, Chiung-Wen
Lin, Yee-Shin
Chen, Chwen-Cheng
Bai, Chyi-Huey
Wu, Shin-Rung
机构
[1] Chung Hwa Coll Med Technol, Dept Nursing, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan
[3] Natl Cheng Kung Univ, Coll Med, Dept Psychiat, Tainan 70101, Taiwan
[4] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan
关键词
cytokines; major depression; serotonin transporter;
D O I
10.1016/j.pnpbp.2006.01.029
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Altered cytokine secretion as a mechanism in the etiology of depression is still obscure. The serotonin transporter (5-HTT) may play an important role in the termination of serotonergic neurotransmission by serotonin (5-HT) uptaking into presynaptic neurons and representing as an initial action site for selective 5-HTT reuptake inhibitors (SSRI). In our study, we evaluated whether cytokines and 5-HTT acted as biological markers for depression. Blood samples were collected from 42 participants. The differences in cytokine and 5-HTT mRNA expressions of leukocytes were assessed between the patients with major depression (n = 20) and the healthy controls (n = 22), along with the measurements prior and after treatment with a SSRI, fluoxetine, for 3 months in the follow-up patient group (n = 8). The results revealed that the mRNA expressions of IL-1 beta, IL-6, IFN gamma, TNF alpha, and 5-HTT were higher in the depressed patients than those of the healthy controls. The higher level of mRNA expressions of IFN gamma and 5-HTT diminished after fluoxetine treatment. Furthermore, we found a positive correlation between 5-HTT and cytokines mRNA expressions in total participants, which suggested that pro-inflammatory cytokines and 5-HTT might play critical roles in the pathogenesis of major depression and that their levels were affected by chronic treatment with 5-HTT inhibitors. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:899 / 905
页数:7
相关论文
共 66 条
[1]   Cytokines, stress, and depressive illness [J].
Anisman, H ;
Merali, Z .
BRAIN BEHAVIOR AND IMMUNITY, 2002, 16 (05) :513-524
[2]   INDUCTION OF CYTOKINE SYNTHESIS AND FEVER SUPPRESSES REM-SLEEP AND IMPROVES MOOD IN PATIENTS WITH MAJOR DEPRESSION [J].
BAUER, J ;
HOHAGEN, F ;
GIMMEL, E ;
BRUNS, F ;
LIS, S ;
KRIEGER, S ;
AMBACH, W ;
GUTHMANN, A ;
GRUNZE, H ;
FRITSCHMONTERO, R ;
WEISSBACH, A ;
GANTER, U ;
FROMMBERGER, U ;
RIEMANN, D ;
BERGER, M .
BIOLOGICAL PSYCHIATRY, 1995, 38 (09) :611-621
[3]   CURRENT ADVANCES AND TRENDS IN THE TREATMENT OF DEPRESSION [J].
BLIER, P ;
DEMONTIGNY, C .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) :220-226
[4]   Interleukin-1β and tumor necrosis factor-α in children with major depressive disorder or dysthymia [J].
Brambilla, F ;
Monteleone, P ;
Maj, M .
JOURNAL OF AFFECTIVE DISORDERS, 2004, 78 (03) :273-277
[5]  
Capuron L, 2003, BRAIN BEHAV IMMUN, V17, pS119
[6]   Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy [J].
Capuron, L ;
Ravaud, A ;
Neveu, PJ ;
Miller, AH ;
Maes, M ;
Dantzer, R .
MOLECULAR PSYCHIATRY, 2002, 7 (05) :468-473
[7]   Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1β in the rat [J].
Castanon, N ;
Bluthé, RM ;
Dantzer, R .
PSYCHOPHARMACOLOGY, 2001, 154 (01) :50-60
[8]  
Charney DS, 1998, J CLIN PSYCHIAT, V59, P11
[9]   Olfactory bulbectomy provokes a suppression of interleukin-1β and tumour necrosis factor-α production in response to an in vivo challenge with lipopolysaccharide:: Effect of chronic desipramine treatment [J].
Connor, TJ ;
Harkin, A ;
Kelly, JP ;
Leonard, BE .
NEUROIMMUNOMODULATION, 2000, 7 (01) :27-35
[10]   Depression, stress and immunological activation: The role of cytokines in depressive disorders [J].
Connor, TJ ;
Leonard, BE .
LIFE SCIENCES, 1998, 62 (07) :583-606